Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial - PubMed
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression - PubMed
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Comparison of venlafaxine alone versus venlafaxine plus bright light therapy combination for severe major depressive disorder - PubMed
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Venlafaxine for neuropathic pain in adults - PubMed
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
サービス「auã®iphone5s ios9.2ã£ã¦ã€ä»Šå¾Œã‚‚mineã§ã¯ä½¿ãˆãªã„ã®ï¼Ÿã€ | Q&A | マイãƒçŽ‹
サービス 2016.01.12 02:07 2016.01.18 06:39
LINEã€ä¸é«˜ç”Ÿã®ã„ã˜ã‚予防ã«ã€Œå›ãŒæŠ¼ã•ãªãゃ誰ãŒæŠ¼ã™ï¼ã€ã‚¹ã‚¿ãƒ³ãƒ—ã‚’ç„¡æ–™é…å¸ƒé–‹å§‹ï¼ - iPhone Mania
LINEã€ä¸é«˜ç”Ÿã®ã„ã˜ã‚予防ã«ã€Œå›ãŒæŠ¼ã•ãªãゃ誰ãŒæŠ¼ã™ï¼ã€ã‚¹ã‚¿ãƒ³ãƒ—ã‚’ç„¡æ–™é…å¸ƒé–‹å§‹ï¼ 2016 3/17 LINEã¯3月15æ—¥ã€ãƒãƒƒãƒˆä¸Šã®ã„ã˜ã‚を防ãå–り組ã¿ã¨ã—ã¦ã€ãƒˆãƒ¼ã‚¯ã®é›°å›²æ°—ãŒæ‚ªããªã£ãŸæ™‚ã«ä½¿ãˆã‚‹ã‚¹ã‚¿ãƒ³ãƒ—ã®ç„¡æ–™é…布を開始ã—ã¾ã—ãŸã€‚NHK教育ã®ãƒ†ãƒ¬ãƒ“番組ã¨ã®å…±åŒä¼ç”»ã§ã™ã€‚ トークã®ç©ºæ°—ã‚’å’Œã¾ã›ã‚‹ã€ãƒ¦ãƒ«ç³»ã‚¹ã‚¿ãƒ³ãƒ— LINEãŒé…布を開始ã—ãŸã®ã¯ã€ãƒˆãƒ¼ã‚¯ã§æ‚ªå£ãŒé£›ã³ã‹ã†ã‚ˆã†ãªç©ºæ°—ã‚’å’Œã¾ã›ã‚‹ “ãŠãŸã™ã‘スタンプâ€ã€Œå›ãŒæŠ¼ã•ãªãゃ誰ãŒæŠ¼ã™ï¼ã€ã§ã€ãƒ¦ãƒ«ã„雰囲気ãŒç‰¹å¾´çš„ã§ã™ã€‚ スタンプã¯ã€NHK教育ã®ç•ªçµ„「ã„ã˜ã‚をノックアウトã€ã«å‡ºæ¼”ã—ãŸä¸é«˜ç”Ÿã‹ã‚‰å‡ºã•ã‚ŒãŸã‚¢ã‚¤ãƒ‡ã‚¢ãŒç™ºç«¯ã¨ãªã‚Šã€å…¨å›½ã®ä¸é«˜ç”Ÿã‹ã‚‰å¯„ã›ã‚‰ã‚ŒãŸç´„3,000件ã‹ã‚‰ã€å‡ºæ¼”者ã®é«˜æ©‹ã¿ãªã¿ã•ã‚“（AKB48）や教育ã®å°‚門家らãŒ8点をé¸è€ƒã—ã¾ã—ãŸã€‚ ãªãŠã€é¸è€ƒä¼šã®æ¨¡æ§˜ã¯3月19日（土）19時放é€åŒç•ªçµ„内ã§ç´¹ä»‹ã•ã‚Œã‚‹äºˆå®šã§ã™ã€‚ 周囲ã«æµã•ã‚Œã€ã„ã˜ã‚ã«åŠ æ‹…ã—
自閉症ã®åŽŸå› ã¨ãªã‚‹éºä¼åãŒæ˜Žã‚‰ã‹ã« - æ±äº¬å¤§å¦åˆ†å細胞生物å¦ç ”究所
æ±äº¬å¤§å¦ã¯3月16æ—¥ã€æ±äº¬å¤§å¦åˆ†å細胞生物å¦ç ”究所ã®ä¸æ‘勉講師らã®ç ”究グループãŒã€ãƒ¤ã‚³ãƒ–セン症候群患者ãŒç™ºç—‡ã™ã‚‹è‡ªé–‰ç—‡ã®åŽŸå› ã¯ã€è„³ã®ç¥žçµŒç´°èƒžã®æ´»å‹•ã‚’抑ãˆã‚‹GABAå—容体ã®é‹æ¬ã«é–¢ä¸Žã™ã‚‹ãŸã‚“ã±ã質「PX-RICSã€ã ã¨ç‰¹å®šã—ãŸã¨ç™ºè¡¨ã—ãŸã€‚今後ã€è‡ªé–‰ç—‡ã®æ–°è–¬ã®é–‹ç™ºã«ã¤ãªãŒã‚‹æœŸå¾…ãŒæŒã¦ã‚‹ã¨ã„ã†ã€‚ 自閉症ã¯ç™ºé”障害ã®ä¸€ã¤ã€‚厚生労åƒçœã«ã‚ˆã‚‹ã¨ã€ç™ºé”障害ã«ã¯ã‚¢ã‚¹ãƒšãƒ«ã‚¬ãƒ¼ç—‡å€™ç¾¤ã‚„注æ„æ¬ å¦‚ãƒ»å¤šå‹•æ€§éšœå®³(ADHD)ãªã©ã‚‚ã‚ã‚Šã€è‡ªé–‰ç—‡ã¯80～100人ã«1人ã®å‰²åˆã§ç™ºç—‡ã™ã‚‹ã¨è¨€ã‚ã‚Œã¦ã„る。「対人関係ã®éšœå®³ã€ã€Œã‚³ãƒŸãƒ¥ãƒ‹ã‚±ãƒ¼ã‚·ãƒ§ãƒ³ã®éšœå®³ã€ã€Œé™å®šçš„ãªèˆˆå‘³ã‚„å¼·ã„ã“ã ã‚ã‚Šã€ãªã©ã®ç—‡çŠ¶ã‚’特徴ã¨ã™ã‚‹ã€‚ 「社会èªçŸ¥æ©Ÿèƒ½ã€ã¨å‘¼ã°ã‚Œã‚‹ä»–者ã®å¿ƒæƒ…を推ã—é‡ã£ãŸã‚Šã€ä»–者ã«å…±æ„Ÿã—ãŸã‚Šã™ã‚‹è„³ã®æ©Ÿèƒ½ã®éšœå®³ãŒè‡ªé–‰ç—‡ã®åŽŸå› ã§ã‚ã‚‹ã¨è€ƒãˆã‚‰ã‚Œã¦ã„ã‚‹ãŒã€ç™ºç—‡ã®è©³ã—ã„仕組ã¿ã¯ã“ã‚Œã¾ã§ã«ã‚ã‹ã£ã¦ã„ãªã‹ã£ãŸã€‚ ç ”ç©¶ã‚°ãƒ«ãƒ¼ãƒ—ã¯å¤§è„³çš®è³ªã‚„海馬ãªã©ã€è„³ã®èªçŸ¥æ©Ÿèƒ½ã«
リリースã€éšœå®³æƒ…å ±ãªã©ã®ã‚µãƒ¼ãƒ“スã®ãŠçŸ¥ã‚‰ã›
最新ã®äººæ°—エントリーã®é…ä¿¡
j次ã®ãƒ–ックマーク
kå‰ã®ãƒ–ックマーク
lã‚ã¨ã§èªã‚€
eコメント一覧を開ã
oページを開ã
{{#tags}}- {{label}}
{{/tags}}